Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PRIVA-FLUOXETINE - Health Canada Drug Approval Details

Approvals/Health Canada/PRIVA-FLUOXETINE

Authorized

STANDARD

PRIVA-FLUOXETINE

pharmapar inc🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 4e893639ef352d5a
Company: pharmapar inc
Type: Standard

Approval Details

Approval Id: 4e893639ef352d5a
Drug Approval Canada Name: PRIVA-FLUOXETINE
Product Name: PRIVA-FLUOXETINE
Status: Cancelled Post Market
Status Date: 2022-07-29
Original Market Date: 2018-12-03
Din: 02448416
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:16.04.20
Atc Original: N06AB03 FLUOXETINE
Atc Name: n 06 ab 03
Aig Number: 0116847003
Company Name: pharmapar inc
Company Address: 1565 Boul Lionel-Boulet, Varennes, Quebec, Canada, J3X 1P7

Active Ingredients

FLUOXETINE (FLUOXETINE HYDROCHLORIDE)

10 MG

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

4e893639ef352d5a

Type

Standard

Back to Health Canada Approvals